Pegaspargase biosimilar - Amega BiotechAlternative Names: PEG-asparaginase biosimilar - Amega Biotech
Latest Information Update: 15 Aug 2013
At a glance
- Originator Amega Biotech
- Class Amidohydrolases; Antineoplastics; Polyethylene glycols
- Mechanism of Action Aspartate-ammonia ligase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Acute lymphoblastic leukaemia
Most Recent Events
- 15 Aug 2013 Investigation in Acute lymphoblastic leukaemia in Argentina (Parenteral)